TYBR Health
New accelerator entry · 2022-02-26 · the record
In their words
TYBR is developing a hydrogel to limit internal scarring after surgery. The naturally derived material is applied to coat tendons at the end of surgery to improve healing outcomes for the millions Americans who undergo tendon or ligament surgery each year.
What the record says
- One of 44 companies held here in Healthcare › Medical Devices.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
The full profile
Source Check, INVEST, RECRUIT and Press Requests on TYBR Health
- Source Check — verify what TYBR Health states, against the registers that hold it.
- INVEST — size up this company on the figures its record states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with TYBR Health for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist TYBR HealthYou get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind TYBR Health: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.